Enrol before | 29 September to save £400 | 20 October to save £200
Discount has been applied to the price above. VAT, if applicable, will be added.
£895.00
The price is for all 6 Modules | Register for Module 1-Free
Improve your understanding of PK/PD studies during drug development
Discount has been applied to the price above. VAT, if applicable, will be added.
Pharmacokinetics is an important discipline, imperative to the development of new medicines. Pharmacokinetic and pharmacodynamic data is gathered throughout drug development and is crucial when designing clinical trials or preparing a drug submission dossier.
This training course provides you with knowledge of the core aspects of pharmacokinetics, so you perform with confidence in your role. You will learn important definitions, how to analyse pharmacokinetic data, the relationship between pharmacokinetics and pharmacodynamics, drug-drug interactions and regulatory requirements. Once completed you will have the knowledge to communicate and interpret the work of PK/PD scientists.
With the Educo Post Learning Implementation Plan (PLIP) you will have the framework to apply and implement the knowledge acquired in the training, supporting you in your development. Learn more about how we deliver both online and classroom training courses.
There are limited spaces on the introductory session. If demand is high you may not be able to attend the live session, however you will be sent the recording. Priority is given to full registrations.
Learn more about the course by toggling through the tabs below (trainer, agenda, who should attend?)
We can customise this course to meet the requirements of your organisation, delivered as a classroom and/or online course.
For more information you can email us at [email protected] or call +44 (0) 203 111 7357.
Complete our contact form by following the link. Get in touch.
* | • The training course is delivered either online or in a classroom. Please check which course format you have booked. |
---|
Reviews
There are no reviews yet.